$EMMA
Emmaus Life Sciences, Inc. Stock $emma

$emma Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000095017024105016 Filed on September 10, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024 Q1
Revenue	$5.478M	$5.377M	$2.506M
YoY Change	9.17%	-50.02%	-62.89%
Cost Of Revenue	$394.0K	$241.0K	$257.0K
YoY Change	84.11%	-52.56%	-40.09%
Gross Profit	$5.084M	$5.136M	$2.249M
YoY Change	5.83%	-49.9%	-64.44%
Gross Profit Margin	92.81%	95.52%	89.74%
Selling, General & Admin	$4.117M	$4.363M	$4.806M
YoY Change	-5.7%	-33.94%	-33.25%
% of Gross Profit	80.98%	84.95%	213.69%
Research & Development	$146.0K	$191.0K	$183.0K
YoY Change	-64.73%	-40.31%	-36.68%
% of Gross Profit	2.87%	3.72%	8.14%
Depreciation & Amortization	$5.000K	$6.000K	$6.000K
YoY Change	-28.57%	-33.33%	-33.33%
% of Gross Profit	0.1%	0.12%	0.27%
Operating Expenses	$4.263M	$4.554M	$4.989M
YoY Change	-10.82%	-34.24%	-33.38%
Operating Profit	$821.0K	$582.0K	-$2.740M
YoY Change	3320.83%	-82.5%	135.19%
Interest Expense	$1.338M	$966.0K	$1.910M
YoY Change	-29.91%	-46.12%	27.16%
% of Operating Profit	162.97%	165.98%
Other Income/Expense, Net		$135.0K	$147.0K
YoY Change		-21.97%	-8.13%
Pretax Income	$1.826M	-$2.153M	-$4.355M
YoY Change	1639.05%	42.02%	25.22%
Income Tax	-$1.000K	$31.00K	-$7.000K
% Of Pretax Income	-0.05%
Net Earnings	$1.827M	-$2.184M	-$4.348M
YoY Change	2626.87%	47.37%	24.23%
Net Earnings / Revenue	33.35%	-40.62%	-173.5%
Basic Earnings Per Share	$0.03	-$0.03	-$0.07
Diluted Earnings Per Share	-$0.01	-$0.03	-$0.07
COMMON SHARES
Basic Shares Outstanding	63.87M	63.36M	61.85M
Diluted Shares Outstanding	162.7M	63.36M	61.85M

Balance Sheet

Concept	2024 Q3	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.525M	$1.712M
YoY Change		12.05%	-3.49%
Cash & Equivalents	$1.255M	$1.525M	$1.712M
Short-Term Investments
Other Short-Term Assets	$817.0K	$654.0K	$762.0K
YoY Change	26.28%	50.69%	90.02%
Inventory	$1.610M	$1.628M	$1.527M
Prepaid Expenses	$364.0K	$279.0K	$442.0K
Receivables	$4.938M	$4.598M	$2.990M
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$9.204M	$9.012M	$7.844M
YoY Change	-0.57%	-8.48%	5.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$49.00K	$54.00K	$57.00K
YoY Change	-18.33%	-20.59%	-20.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$14.66M	$19.25M
YoY Change		-19.89%	0.75%
Other Assets	$312.0K	$308.0K	$310.0K
YoY Change	6.48%	11.59%	11.91%
Total Long-Term Assets	$18.14M	$16.93M	$21.70M
YoY Change	-52.51%	-58.14%	-47.75%
TOTAL ASSETS
Total Short-Term Assets	$9.204M	$9.012M	$7.844M
Total Long-Term Assets	$18.14M	$16.93M	$21.70M
Total Assets	$27.34M	$25.94M	$29.54M
YoY Change	-42.38%	-48.42%	-39.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.489M	$7.214M	$6.565M
YoY Change	35.05%	109.65%	38.71%
Accrued Expenses	$7.864M	$8.163M	$8.519M
YoY Change	-3.67%	-8.85%	26.81%
Deferred Revenue
YoY Change
Short-Term Debt		$5.572M	$4.132M
YoY Change			-26.75%
Long-Term Debt Due		$24.21M	$24.31M
YoY Change		-20.54%	5.63%
Total Short-Term Liabilities	$64.13M	$64.03M	$62.43M
YoY Change	5.28%	4.03%	7.9%
LONG-TERM LIABILITIES
Long-Term Debt		$2.236M	$2.231M
YoY Change		-34.54%	-49.59%
Other Long-Term Liabilities	$13.68M	$15.37M	$16.97M
YoY Change	-20.67%	-15.23%	-16.24%
Total Long-Term Liabilities	$13.68M	$15.37M	$16.97M
YoY Change	-20.67%	-15.23%	-16.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$64.13M	$64.03M	$62.43M
Total Long-Term Liabilities	$13.68M	$15.37M	$16.97M
Total Liabilities	$81.12M	$82.95M	$83.19M
YoY Change	-3.17%	-2.77%	-2.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$260.8M	-$262.7M	-$260.5M
YoY Change	1.36%	2.05%	1.78%
Common Stock	$225.9M	$225.9M	$225.6M
YoY Change	1.55%	1.54%	1.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$53.78M	-$57.01M	-$53.64M
YoY Change
Total Liabilities & Shareholders Equity	$27.34M	$25.94M	$29.54M
YoY Change	-42.38%	-48.42%	-39.64%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$1.827M	-$2.184M	-$4.348M
YoY Change	2626.87%	47.37%	24.23%
Depreciation, Depletion And Amortization	$5.000K	$6.000K	$6.000K
YoY Change	-28.57%	-33.33%	-33.33%
Cash From Operating Activities		-$2.917M	$140.0K
YoY Change		123.52%	-110.84%
INVESTING ACTIVITIES
Capital Expenditures		$3.000K	$4.000K
YoY Change		-40.0%	-33.33%
Acquisitions
YoY Change
Other Investing Activities		$2.508M	$0.00
YoY Change		134.61%	-100.0%
Cash From Investing Activities		$2.505M	-$4.000K
YoY Change		135.43%	-99.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		235.0K	-955.0K
YoY Change		-253.59%	-144.61%
NET CHANGE
Cash From Operating Activities		-2.917M	140.0K
Cash From Investing Activities		2.505M	-4.000K
Cash From Financing Activities		235.0K	-955.0K
Net Change In Cash		-177.0K	-835.0K
YoY Change		-55.08%	238.06%
FREE CASH FLOW
Cash From Operating Activities		-$2.917M	$140.0K
Capital Expenditures		$3.000K	$4.000K
Free Cash Flow		-$2.920M	$136.0K
YoY Change		122.9%	-110.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0000822370
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1727000
CY2024Q2	us-gaap	Assets Current AssetsCurrent	9012000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	11509000
	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://www.emmausmedical.com/20240630#GainLossOnInvestmentInConvertibleBond
CY2023	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList	http://www.emmausmedical.com/20240630#GainLossOnInvestmentInConvertibleBond
	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2023	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Gain Loss Statement Of Other Comprehensive Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfOtherComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35527
	dei	Entity Registrant Name EntityRegistrantName	EMMAUS LIFE SCIENCES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0419387
	dei	Entity Address Address Line1 EntityAddressAddressLine1	21250 Hawthorne Boulevard
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 800
	dei	Entity Address City Or Town EntityAddressCityOrTown	Torrance
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90503
	dei	City Area Code CityAreaCode	310
	dei	Local Phone Number LocalPhoneNumber	214-0065
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	63865571
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1525000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2547000
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4598000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5524000
CY2024Q2	us-gaap	Inventory Net InventoryNet	1628000
CY2023Q4	us-gaap	Inventory Net InventoryNet	1711000
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1261000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1727000
CY2024Q2	us-gaap	Assets Current AssetsCurrent	9012000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	11509000
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	54000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59000
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1903000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2337000
CY2024Q2	emma	Investment In Convertible Bond InvestmentInConvertibleBond	14662000
CY2023Q4	emma	Investment In Convertible Bond InvestmentInConvertibleBond	20978000
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	308000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	296000
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	54000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59000
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1903000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2337000
CY2024Q2	emma	Investment In Convertible Bond InvestmentInConvertibleBond	14662000
CY2023Q4	emma	Investment In Convertible Bond InvestmentInConvertibleBond	20978000
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	308000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	296000
CY2024Q2	us-gaap	Assets Assets	25939000
CY2023Q4	us-gaap	Assets Assets	35179000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17725000
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	903000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	865000
CY2023Q4	emma	Conversion Feature Derivative Note Payable ConversionFeatureDerivativeNotePayable	451000
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14353000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14681000
CY2024Q2	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	69000
CY2023Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	65000
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	16329000
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	16383000
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	64025000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17363000
CY2024Q2	us-gaap	Liabilities Liabilities	82953000
CY2023Q4	us-gaap	Liabilities Liabilities	82935000
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63865571
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63865571
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61845963
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61845963
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	64000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	62000
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	225839000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	225333000
CY2024Q2	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	16869000
CY2023Q4	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	16869000
CY2024Q2	us-gaap	Assets Assets	25939000
CY2023Q4	us-gaap	Assets Assets	35179000
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	18920000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17725000
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	903000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	865000
CY2024Q2	emma	Conversion Feature Derivative Note Payable ConversionFeatureDerivativeNotePayable	2800000
CY2023Q4	emma	Conversion Feature Derivative Note Payable ConversionFeatureDerivativeNotePayable	451000
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14353000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14681000
CY2024Q2	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	69000
CY2023Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	65000
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	16329000
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	16383000
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	64025000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	61507000
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1322000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1839000
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15370000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17363000
CY2024Q2	us-gaap	Liabilities Liabilities	82953000
CY2023Q4	us-gaap	Liabilities Liabilities	82935000
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63865571
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63865571
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61845963
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	61845963
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	64000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	62000
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	225839000
CY2024Q2	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	16869000
CY2023Q4	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	16869000
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3394000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-160000
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-262654000
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3394000
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-262654000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-256122000
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-57014000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-47756000
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25939000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35179000
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5377000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10759000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7883000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17512000
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	241000
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	508000
	us-gaap	Cost Of Revenue CostOfRevenue	498000
	us-gaap	Cost Of Revenue CostOfRevenue	937000
CY2024Q2	us-gaap	Gross Profit GrossProfit	5136000
CY2023Q2	us-gaap	Gross Profit GrossProfit	10251000
	us-gaap	Gross Profit GrossProfit	7385000
	us-gaap	Gross Profit GrossProfit	16575000
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	191000
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	320000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	374000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	609000
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1631000
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2531000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3568000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4848000
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2732000
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4074000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5601000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8957000
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	4554000
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	6925000
	us-gaap	Operating Expenses OperatingExpenses	9543000
	us-gaap	Operating Expenses OperatingExpenses	14414000
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	582000
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3326000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2158000
	us-gaap	Operating Income Loss OperatingIncomeLoss	2161000
CY2024Q2	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	5000
CY2023Q2	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	383000
	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	-3000
	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	445000
CY2024Q2	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-1440000
CY2023Q2	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-1058000
	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-2347000
	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-969000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10759000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7883000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17512000
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	241000
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	508000
	us-gaap	Cost Of Revenue CostOfRevenue	498000
	us-gaap	Cost Of Revenue CostOfRevenue	937000
CY2024Q2	us-gaap	Gross Profit GrossProfit	5136000
CY2023Q2	us-gaap	Gross Profit GrossProfit	10251000
	us-gaap	Gross Profit GrossProfit	7385000
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	191000
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	320000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	374000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	609000
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1631000
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2531000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3568000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4848000
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2732000
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4074000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5601000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8957000
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	4554000
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	6925000
	us-gaap	Operating Expenses OperatingExpenses	9543000
	us-gaap	Operating Expenses OperatingExpenses	14414000
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	582000
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3326000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2158000
	us-gaap	Operating Income Loss OperatingIncomeLoss	2161000
CY2024Q2	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	5000
CY2023Q2	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	383000
	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	445000
CY2024Q2	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-1440000
CY2023Q2	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-1058000
	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-969000
CY2024Q2	emma	Gain Loss On Investment In Convertible Bond GainLossOnInvestmentInConvertibleBond	-544000
CY2023Q2	emma	Gain Loss On Investment In Convertible Bond GainLossOnInvestmentInConvertibleBond	-297000
	emma	Gain Loss On Investment In Convertible Bond GainLossOnInvestmentInConvertibleBond	-544000
	emma	Gain Loss On Investment In Convertible Bond GainLossOnInvestmentInConvertibleBond	-297000
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-439000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-966000
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	1032000
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	75000
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1887000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	106000
CY2024Q2	emma	Gain Loss On Investment In Convertible Bond GainLossOnInvestmentInConvertibleBond	-544000
CY2023Q2	emma	Gain Loss On Investment In Convertible Bond GainLossOnInvestmentInConvertibleBond	-297000
	emma	Gain Loss On Investment In Convertible Bond GainLossOnInvestmentInConvertibleBond	-544000
	emma	Gain Loss On Investment In Convertible Bond GainLossOnInvestmentInConvertibleBond	-297000
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-439000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-966000
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	1032000
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	75000
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1887000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	106000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2406000
CY2024Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	135000
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	173000
	us-gaap	Interest And Other Income InterestAndOtherIncome	282000
	us-gaap	Interest And Other Income InterestAndOtherIncome	333000
CY2024Q2	us-gaap	Interest Expense InterestExpense	966000
CY2023Q2	us-gaap	Interest Expense InterestExpense	1793000
	us-gaap	Interest Expense InterestExpense	2876000
	us-gaap	Interest Expense InterestExpense	3295000
CY2024Q2	emma	Nonoperating Income Expense Including Income Loss From Equity Method Investments NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments	-2735000
CY2023Q2	emma	Nonoperating Income Expense Including Income Loss From Equity Method Investments NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments	-4918000
	emma	Nonoperating Income Expense Including Income Loss From Equity Method Investments NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments	-4350000
	emma	Nonoperating Income Expense Including Income Loss From Equity Method Investments NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments	-7155000
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2153000
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1592000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6508000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4994000
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-34000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2184000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1558000
	us-gaap	Net Income Loss NetIncomeLoss	-6532000
	us-gaap	Net Income Loss NetIncomeLoss	-5009000
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1733000
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1909000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3461000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1365000
CY2024Q2	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	197000
CY2023Q2	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	403000
	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	197000
	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	403000
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	12000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	551000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2406000
CY2024Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	135000
CY2023Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	173000
	us-gaap	Interest And Other Income InterestAndOtherIncome	282000
	us-gaap	Interest And Other Income InterestAndOtherIncome	333000
CY2024Q2	us-gaap	Interest Expense InterestExpense	966000
CY2023Q2	us-gaap	Interest Expense InterestExpense	1793000
	us-gaap	Interest Expense InterestExpense	2876000
	us-gaap	Interest Expense InterestExpense	3295000
CY2024Q2	emma	Nonoperating Income Expense Including Income Loss From Equity Method Investments NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments	-2735000
CY2023Q2	emma	Nonoperating Income Expense Including Income Loss From Equity Method Investments NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments	-4918000
	emma	Nonoperating Income Expense Including Income Loss From Equity Method Investments NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments	-4350000
	emma	Nonoperating Income Expense Including Income Loss From Equity Method Investments NonoperatingIncomeExpenseIncludingIncomeLossFromEquityMethodInvestments	-7155000
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2153000
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1592000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6508000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4994000
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2184000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1558000
	us-gaap	Net Income Loss NetIncomeLoss	-6532000
	us-gaap	Net Income Loss NetIncomeLoss	-5009000
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1733000
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1909000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3461000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1365000
CY2024Q2	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	197000
CY2023Q2	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	403000
	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	197000
	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	403000
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	12000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	30000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	737000
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1524000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2505000
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3708000
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1305000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9766000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2504000
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	30000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	737000
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1524000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2863000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3234000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2505000
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3708000
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1305000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9766000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2504000
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63355121
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63355121
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52865353
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52865353
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62600542
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62600542
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51793445
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51793445
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-47756000
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	170000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	18000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4348000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-53644000
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	309000
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	29000
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1733000
CY2024Q2	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	197000
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	12000
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2184000
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-57014000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-34091000
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	500000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38000
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-544000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	186000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3451000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-37362000
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1000000
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63355121
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63355121
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52865353
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52865353
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62600542
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62600542
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51793445
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51793445
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-47756000
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	170000
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1728000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	18000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4348000
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-53644000
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	309000
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	29000
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1733000
CY2024Q2	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	197000
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	12000
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2184000
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-57014000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-34091000
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	500000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38000
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-544000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	186000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3451000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-37362000
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1909000
CY2023Q2	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	403000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	551000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1558000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-35032000
	us-gaap	Profit Loss ProfitLoss	-6532000
	us-gaap	Profit Loss ProfitLoss	-5009000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18000
	emma	Inventory Reserve InventoryReserve	-15000
	emma	Inventory Reserve InventoryReserve	-16000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	563000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1266000
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	194000
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2382000
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-544000
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-297000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-966000
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1909000
CY2023Q2	emma	Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss OtherComprehensiveIncomeLossReclassificationAdjustmentForLossIncludedInNetIncomeLoss	403000
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	551000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1558000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-35032000
	us-gaap	Profit Loss ProfitLoss	-6532000
	us-gaap	Profit Loss ProfitLoss	-5009000
	emma	Inventory Reserve InventoryReserve	-15000
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	194000
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-297000
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	1032000
	us-gaap	Share Based Compensation ShareBasedCompensation	199000
	us-gaap	Share Based Compensation ShareBasedCompensation	1215000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	334000
	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	-3000
	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	445000
	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-2347000
	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-969000
	emma	Gain Loss On Option Instrument GainLossOnOptionInstrument	7000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-921000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5204000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-47000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-543000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-471000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2681000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-316000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-101000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2436000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2777000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2597000
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2508000
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2232000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11000
	emma	Loan To Equity Method Investee LoanToEquityMethodInvestee	-2248000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2501000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2401000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2453000
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	227000
	emma	Proceeds From Related Party Convertible Debt ProceedsFromRelatedPartyConvertibleDebt	1000000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2571000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1642000
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	350000
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	50000
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	200000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-720000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1988000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-26000
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	1032000
	us-gaap	Share Based Compensation ShareBasedCompensation	199000
	us-gaap	Share Based Compensation ShareBasedCompensation	1215000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	334000
	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	-3000
	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	445000
	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-2347000
	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-969000
	emma	Gain Loss On Option Instrument GainLossOnOptionInstrument	7000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-921000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5204000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-47000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-543000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-471000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-331000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-412000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-282000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2229000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2201000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2681000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-316000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-101000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2436000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2777000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2597000
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2508000
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2232000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11000
	emma	Loan To Equity Method Investee LoanToEquityMethodInvestee	-2248000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2501000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2401000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2453000
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	227000
	emma	Proceeds From Related Party Convertible Debt ProceedsFromRelatedPartyConvertibleDebt	1000000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2571000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1642000
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	350000
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	50000
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	200000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-720000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1988000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-26000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-24000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1022000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-660000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2547000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2021000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-24000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1022000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-660000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2547000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2021000
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1525000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1361000
	us-gaap	Interest Paid Net InterestPaidNet	1234000
	us-gaap	Interest Paid Net InterestPaidNet	1018000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	29000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-68000
	emma	Renewal Of Notes Payable Including Interests Capitalized RenewalOfNotesPayableIncludingInterestsCapitalized	618000
	emma	Conversion Of Convertible Note Payable And Accrued Interest To Common Stock ConversionOfConvertibleNotePayableAndAccruedInterestToCommonStock	309000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	112986381
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	69300024
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5377000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10759000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7883000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17512000
CY2023Q4	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	7733000
	emma	Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear	2571000
	emma	Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales	45000
	emma	Revenue Allowance And Accrual Activities Credit And Payments Made RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade	2395000
CY2024Q2	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	7864000
CY2022Q4	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	5491000
	emma	Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear	3570000
	emma	Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales	77000
	emma	Revenue Allowance And Accrual Activities Credit And Payments Made RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade	3359000
CY2023Q2	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	5625000
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1525000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1361000
	us-gaap	Interest Paid Net InterestPaidNet	1234000
	us-gaap	Interest Paid Net InterestPaidNet	1018000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	29000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-68000
	emma	Renewal Of Notes Payable Including Interests Capitalized RenewalOfNotesPayableIncludingInterestsCapitalized	618000
	emma	Conversion Of Convertible Note Payable And Accrued Interest To Common Stock ConversionOfConvertibleNotePayableAndAccruedInterestToCommonStock	309000
	emma	Conversion Of Convertible Note Payable And Accrued Interest To Common Stock ConversionOfConvertibleNotePayableAndAccruedInterestToCommonStock	1500000
	us-gaap	Net Income Loss NetIncomeLoss	-6500000
CY2024Q2	emma	Working Capital Deficit WorkingCapitalDeficit	55000000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	112986381
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	69300024
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5377000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17512000
CY2023Q4	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	7733000
	emma	Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear	2571000
	emma	Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales	45000
	emma	Revenue Allowance And Accrual Activities Credit And Payments Made RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade	2395000
CY2024Q2	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	7864000
	emma	Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear	3570000
	emma	Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales	77000
	emma	Revenue Allowance And Accrual Activities Credit And Payments Made RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade	3359000
CY2023Q2	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	5625000
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1266000
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1329000
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	285000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	186000
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5059000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5163000
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4982000
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4967000
CY2024Q2	us-gaap	Inventory Net InventoryNet	1628000
CY2023Q4	us-gaap	Inventory Net InventoryNet	1711000
CY2024Q2	us-gaap	Prepaid Insurance PrepaidInsurance	328000
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	595000
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	279000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	536000
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	654000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	596000
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1261000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1727000
CY2024Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1266000
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1329000
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	285000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	186000
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5059000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5163000
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4982000
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4967000
CY2024Q2	us-gaap	Inventory Net InventoryNet	1628000
CY2023Q4	us-gaap	Inventory Net InventoryNet	1711000
CY2024Q2	us-gaap	Prepaid Insurance PrepaidInsurance	328000
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	595000
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	279000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	536000
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	654000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	596000
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1261000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1727000
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	524000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	521000
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	470000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	462000
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	54000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59000
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	524000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	521000
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	470000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	462000
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	54000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59000
CY2024Q2	us-gaap	Depreciation Depreciation	6000
CY2023Q2	us-gaap	Depreciation Depreciation	9000
	us-gaap	Depreciation Depreciation	12000
	us-gaap	Depreciation Depreciation	18000
CY2020Q3	us-gaap	Debt Instrument Call Date Earliest DebtInstrumentCallDateEarliest	2020-09-28
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	106000
CY2024Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-347000
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	20978000
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	19971000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-2508000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-2232000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-347000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	106000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-3461000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	3133000
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	20978000
CY2024Q2	us-gaap	Depreciation Depreciation	6000
CY2023Q2	us-gaap	Depreciation Depreciation	9000
	us-gaap	Depreciation Depreciation	12000
	us-gaap	Depreciation Depreciation	18000
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	106000
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	20978000
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	19971000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-2508000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-2232000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-347000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	106000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-3461000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	3133000
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	14662000
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	20978000
CY2024Q2	emma	Clinical And Regulatory Expenses ClinicalAndRegulatoryExpenses	749000
CY2023Q4	emma	Clinical And Regulatory Expenses ClinicalAndRegulatoryExpenses	696000
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	874000
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	721000
CY2024Q2	emma	Accrued Selling Expenses AccruedSellingExpenses	2253000
CY2023Q4	emma	Accrued Selling Expenses AccruedSellingExpenses	1498000
CY2024Q2	emma	Accrued Manufacturing Expenses Current AccruedManufacturingExpensesCurrent	737000
CY2023Q4	emma	Accrued Manufacturing Expenses Current AccruedManufacturingExpensesCurrent	914000
CY2024Q2	emma	Accruednonemployeeboardmembercompensation Accruednonemployeeboardmembercompensation	912000
CY2023Q4	emma	Accruednonemployeeboardmembercompensation Accruednonemployeeboardmembercompensation	766000
CY2024Q2	emma	Clinical And Regulatory Expenses ClinicalAndRegulatoryExpenses	749000
CY2023Q4	emma	Clinical And Regulatory Expenses ClinicalAndRegulatoryExpenses	696000
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	874000
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	721000
CY2024Q2	emma	Accrued Selling Expenses AccruedSellingExpenses	2253000
CY2023Q4	emma	Accrued Selling Expenses AccruedSellingExpenses	1498000
CY2024Q2	emma	Accrued Manufacturing Expenses Current AccruedManufacturingExpensesCurrent	737000
CY2023Q4	emma	Accrued Manufacturing Expenses Current AccruedManufacturingExpensesCurrent	914000
CY2024Q2	emma	Accruednonemployeeboardmembercompensation Accruednonemployeeboardmembercompensation	912000
CY2023Q4	emma	Accruednonemployeeboardmembercompensation Accruednonemployeeboardmembercompensation	766000
CY2024Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1689000
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1292000
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	7214000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5887000
CY2024Q2	emma	Interest Payable Related Parties Current InterestPayableRelatedPartiesCurrent	705000
CY2023Q4	emma	Interest Payable Related Parties Current InterestPayableRelatedPartiesCurrent	542000
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	2838000
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3122000
CY2024Q2	emma	Accrued Payroll Salary And Taxes Current AccruedPayrollSalaryAndTaxesCurrent	1141000
CY2023Q4	emma	Accrued Payroll Salary And Taxes Current AccruedPayrollSalaryAndTaxesCurrent	1270000
CY2024Q2	emma	Accrued Government Rebates And Other Rebates Current AccruedGovernmentRebatesAndOtherRebatesCurrent	6938000
CY2023Q4	emma	Accrued Government Rebates And Other Rebates Current AccruedGovernmentRebatesAndOtherRebatesCurrent	5881000
CY2023Q4	emma	Accured Due To Customer Current AccuredDueToCustomerCurrent	844000
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	84000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	179000
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8163000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8174000
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	18920000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17725000
CY2024Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1689000
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	7214000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5887000
CY2024Q2	emma	Interest Payable Related Parties Current InterestPayableRelatedPartiesCurrent	705000
CY2023Q4	emma	Interest Payable Related Parties Current InterestPayableRelatedPartiesCurrent	542000
CY2024Q2	emma	Accrued Payroll Salary And Taxes Current AccruedPayrollSalaryAndTaxesCurrent	1141000
CY2023Q4	emma	Accrued Payroll Salary And Taxes Current AccruedPayrollSalaryAndTaxesCurrent	1270000
CY2024Q2	emma	Accrued Government Rebates And Other Rebates Current AccruedGovernmentRebatesAndOtherRebatesCurrent	6938000
CY2023Q4	emma	Accured Due To Customer Current AccuredDueToCustomerCurrent	844000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8174000
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	18920000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17725000
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14353000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14681000
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15370000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17363000
CY2024Q2	emma	Debt Instrument Principal Outstanding Amount DebtInstrumentPrincipalOutstandingAmount	29371000
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	154000
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	29217000
	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	103312575
CY2023Q4	emma	Debt Instrument Principal Outstanding Amount DebtInstrumentPrincipalOutstandingAmount	30563000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	617000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	29946000
CY2023	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	116906234
CY2024Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.02
CY2024Q2	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.13
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.12
CY2024Q2	emma	Debt Weighted Average Effective Interest Rate DebtWeightedAverageEffectiveInterestRate	0.14
CY2023Q4	emma	Debt Weighted Average Effective Interest Rate DebtWeightedAverageEffectiveInterestRate	0.23
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14353000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14681000
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15370000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17363000
CY2024Q2	emma	Debt Instrument Principal Outstanding Amount DebtInstrumentPrincipalOutstandingAmount	29371000
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	154000
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	29217000
	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	103312575
CY2023Q4	emma	Debt Instrument Principal Outstanding Amount DebtInstrumentPrincipalOutstandingAmount	30563000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	617000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	29946000
CY2023	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	116906234
CY2024Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.02
CY2024Q2	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.13
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.12
CY2023Q4	emma	Debt Weighted Average Effective Interest Rate DebtWeightedAverageEffectiveInterestRate	0.23
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	27050000
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2321000
CY2024Q1	emma	Fair Value Of Conversion Feature Liability FairValueOfConversionFeatureLiability	2000
CY2022Q3	emma	Warrants Granted Term WarrantsGrantedTerm	P5Y
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	500000
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.5
CY2023Q2	emma	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	18000
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	27050000
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2321000
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	29371000
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	32000
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	84000
CY2024Q2	emma	Fair Value Of Conversion Feature Liability FairValueOfConversionFeatureLiability	1000
CY2024Q1	emma	Fair Value Of Conversion Feature Liability FairValueOfConversionFeatureLiability	2000
CY2022Q3	emma	Warrants Granted Term WarrantsGrantedTerm	P5Y
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	500000
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.5
CY2023Q2	emma	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	18000
	emma	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	4000
CY2023Q1	emma	Warrants Granted Term WarrantsGrantedTerm	P5Y
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.5
	us-gaap	Share Based Compensation ShareBasedCompensation	1200000
CY2023Q2	emma	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	304000
	emma	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	286000
CY2023Q1	emma	Warrant Expired Date WarrantExpiredDate	2023-11
	emma	Summary Of Assumptions Used To Value Warrants SummaryOfAssumptionsUsedToValueWarrants	<p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the assumptions used to value the warrants:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:31.72%;"></td> <td style="width:2.6%;"></td> <td style="width:1%;"></td> <td style="width:17.66%;"></td> <td style="width:1%;"></td> <td style="width:2.6%;"></td> <td style="width:1%;"></td> <td style="width:16.74%;"></td> <td style="width:1%;"></td> <td style="width:2.6%;"></td> <td style="width:1%;"></td> <td style="width:20.08%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock price</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.10</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.10</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.23</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercise price</span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.47</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.50</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.47</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.50</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.47</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.50</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected term</span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.53</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.58</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.03</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.24 </span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">years</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.11</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.58 </span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">years</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.47</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.90</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.92</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.21</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.58</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dividend yield</span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Volatility</span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.42</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">145.16</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">129.40</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">130.23</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">128.78</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">134.9</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
	emma	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	4000
CY2023Q1	emma	Warrants Granted Term WarrantsGrantedTerm	P5Y
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.5
	us-gaap	Share Based Compensation ShareBasedCompensation	1200000
CY2023Q2	emma	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	304000
	emma	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	286000
CY2023Q1	emma	Warrant Expired Date WarrantExpiredDate	2023-11
	emma	Summary Of Assumptions Used To Value Warrants SummaryOfAssumptionsUsedToValueWarrants	<p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the assumptions used to value the warrants:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:31.72%;"></td> <td style="width:2.6%;"></td> <td style="width:1%;"></td> <td style="width:17.66%;"></td> <td style="width:1%;"></td> <td style="width:2.6%;"></td> <td style="width:1%;"></td> <td style="width:16.74%;"></td> <td style="width:1%;"></td> <td style="width:2.6%;"></td> <td style="width:1%;"></td> <td style="width:20.08%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">June 30, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Stock price</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.10</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.10</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.23</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Exercise price</span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.47</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.50</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.47</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.50</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">$</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.47</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - $</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.50</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected term</span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.53</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.58</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.03</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.24 </span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">years</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.11</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.58 </span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">years</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.47</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.90</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.92</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.21</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.58</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Dividend yield</span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Volatility</span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">144.42</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">145.16</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">129.40</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">130.23</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">128.78</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%-</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">134.9</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">%</span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y7M6D
CY2024Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	31000
CY2023Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-34000
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	24000
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	15000
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	289000
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	307000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	590000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	587000
CY2024Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	31000
CY2023Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-34000
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	24000
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	15000
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	289000
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	307000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	590000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	587000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	554000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1132000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	846000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2532000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	307000
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2225000
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1900000
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2200000
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.129
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	554000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1132000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	846000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2532000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	307000
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2225000
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1900000
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2200000
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.129

Files In Submission

Name	View Source	Status
0000950170-24-105016-index-headers.html	Edgar Link	pending
0000950170-24-105016-index.html	Edgar Link	pending
0000950170-24-105016.txt	Edgar Link	pending
0000950170-24-105016-xbrl.zip	Edgar Link	pending
emma-20240630.htm	Edgar Link	pending
emma-20240630.xsd	Edgar Link	pending
emma-ex10_1.htm	Edgar Link	pending
emma-ex31_1.htm	Edgar Link	pending
emma-ex31_2.htm	Edgar Link	pending
emma-ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img109337448_0.jpg	Edgar Link	pending
img109337448_1.jpg	Edgar Link	pending
img109337448_2.jpg	Edgar Link	pending
img109337448_3.jpg	Edgar Link	pending
img109337448_4.jpg	Edgar Link	pending
img109337448_5.jpg	Edgar Link	pending
img109337448_6.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
emma-20240630_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EMMA
Emmaus Life Sciences, Inc. Stock $emma

2024 Q3 Form 10-Q Financial Statement

#000095017024105016 Filed on September 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EMMA Emmaus Life Sciences, Inc. Stock $emma

2024 Q3 Form 10-Q Financial Statement

#000095017024105016 Filed on September 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EMMA
Emmaus Life Sciences, Inc. Stock $emma